Basic Information
Beacon's EEG Neurobiomarker Platform is designed to accelerate clinical trials and provide new treatment options for patients with neurological and psychiatric disorders. Through advanced machine learning algorithms, extensive datasets, and progress in software engineering, we are transforming the way patients address brain-related diseases.
Beacon Biosignals, Inc.
Boston,Massachusetts,United States of America
15~50 people
January 01, 2019
--

